Alexis Borisy is CEO and chairman of EQRx, and a long-time biotech builder with Third Rock Ventures. His conversation with Nature Biotechnology covers growing up as a ‘faculty brat’ in Wisconsin, dropping out of his PhD program at Harvard and why, even to an investor, biotech cannot be all about the money.
Rights and permissions
About this article
Cite this article
First rounders: Alexis Borisy. Nat Biotechnol 38, 699 (2020). https://doi.org/10.1038/s41587-020-0542-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-020-0542-z
